Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B78ebee88dff75970f85ca12e0d66093a> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B78ebee88dff75970f85ca12e0d66093a NCIT_P378 "NCI" @default.
- B78ebee88dff75970f85ca12e0d66093a type Axiom @default.
- B78ebee88dff75970f85ca12e0d66093a annotatedProperty IAO_0000115 @default.
- B78ebee88dff75970f85ca12e0d66093a annotatedSource NCIT_C112495 @default.
- B78ebee88dff75970f85ca12e0d66093a annotatedTarget "A preparation of cytotoxic, autologous lymphoid effector cells specifically targeted towards tumor cells, with potential immunomodulating and antineoplastic activities. The autologous lymphoid effector cells are prepared by drawing a blood sample containing the required precursors for CD4+ helper T-cells, CD8+ cytotoxic T-cells, and natural killer (NK) cells from a cancer patient. The precursor cells are activated, selected and expanded to generate mature autologous lymphoid effector cells with the potential for enhanced tumor recognition. Upon readministration into the patient, the autologous lymphoid effector cells may induce both humoral and cellular immune responses against tumor cells. This may result in the immune-mediated inhibition of tumor cell proliferation, which leads to tumor cell death." @default.